Featured Post

[TWR, 2025년 5월 19-23일] 대한민국 주요 5대 산업 주간 주가 예측 보고서

I. Executive Summary 본 보고서는 2025년 5월 19일부터 23일까지 예정된 미국의 주요 경제 지표 발표 일정과 주요 산업 컨퍼런스(CLEANPOWER 2025, TPD & Induced Proximity Pharma Part...

Popular Posts

Saturday, July 12, 2025

In-Depth Analysis of the KOSDAQ Market

KOSDAQ Market In-Depth Analysis: Challenges and Opportunities

In-Depth Analysis of the KOSDAQ Market

Current Challenges and Proposals for a Resurgence

This report diagnoses the structural limitations of the KOSDAQ market from a foreign investor's perspective and proposes policy directions for its transformation into a sustainable innovation ecosystem. Click the tabs below to explore the information interactively.

Why Do Foreign Investors Overlook KOSDAQ?

The challenges facing the KOSDAQ market stem from a complex mix of macroeconomic factors, internal market issues, and individual company-level problems.

🌍Macro Investment Environment

  • Rise of Passive Investing: Global capital follows indices, structurally sidelining KOSDAQ due to its minimal weight in major benchmarks.
  • High FX Volatility: During geopolitical risks, the Korean Won's depreciation raises currency loss concerns, prompting foreign investors to sell risk assets like KOSDAQ stocks.

🏛️Internal Market Flaws

  • Structural Vulnerability: Heavy concentration in specific sectors like biotech, and a "hollowing out" as successful firms move to KOSPI.
  • Crisis of Trust: Recurring scandals, opaque accounting, and weak corporate governance are key deterrents.
  • Ambiguous Identity: Lacks a clear role and vision, caught between the large-cap KOSPI and the early-stage KONEX market.

🏢Difficulty in Corporate Valuation

  • Information Asymmetry: Lack of professional analyst coverage and insufficient English disclosures increase information acquisition costs.
  • Valuation Dilemma: Many biotech and AI firms with unpredictable future cash flows make traditional valuation models (like DCF) difficult to apply.

Structural Vulnerability: Sector Concentration

KOSDAQ's market capitalization is dominated by a few specific sectors, particularly pharma/biotech and secondary batteries. This creates systemic risk, where the entire market can be swayed by the performance of these industries. Hover over the chart to see the weight of each sector.

Hover over a section of the chart to see representative company information.

The Valuation Dilemma: Interactive WACC Experience

The discount rate (WACC), a core component of valuation, varies significantly with market risk (Beta) and expected returns (MRP). KOSDAQ firms often have high Betas due to volatility, which can lead to undervaluation. Adjust the sliders below to see how WACC changes in real-time.

Calculated Weighted Average Cost of Capital (WACC)

9.28%

(Assuming Risk-Free Rate: 2.5%, Cost of Debt: 3.0%, Tax Rate: 24%, Capital Structure E:D 95:5)

#KOSDAQ #ForeignInvestment #Valuation #CorporateGovernance #TechStocks #Biotech #SecondaryBattery #PolicyProposal #KoreanStockMarket #EmergingMarkets #Innovation #VentureCapital #DCF #WACC #MarketStructure #InvestorTrust #Semiconductor #AI #OLED #FinancialRegulation #CapitalMarkets #FXRisk #PassiveInvesting #InformationAsymmetry #KoreaDiscount #StockMarketAnalysis #EconomicPolicy #GrowthStocks #M&A #InvestorRelations

This material is an AI-generated analytical example based on the provided report and is not a recommendation to buy or sell any specific stock.
The judgment and responsibility for investment rest solely with the investor.

Source: bboongfree.blogspot.com